Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows (Unaudited)

v3.7.0.1
Condensed Statement of Cash Flows (Unaudited)
 6 Months Ended
Jun. 30, 2017
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (25,967)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (55,729)
Changes in operating assets and liabilities:  
Prepaid expenses (29,908)
Accrued expenses 34,651
Net cash used in operating activities (76,953)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (116,150,000)
Net cash used in investing activities (116,150,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units, net of underwriting discounts paid 112,125,000
Proceeds from sale of Private Units 5,025,000
Proceeds from note payable - related party 51,521
Repayment of note payable - related party (191,521)
Payment of offering costs (272,686)
Net cash provided by financing activities 116,737,314
Net Change in Cash and Cash Equivalents 510,361
Cash and Cash Equivalents - Beginning 67,250
Cash and Cash Equivalents - Ending 577,611
Non-Cash investing and financing activities:  
Deferred underwriting fees charged to additional paid in capital 4,025,000
Initial classification of common stock subject to possible redemption 107,662,332
Change in value of common stock subject to possible redemption 13,152
Offering costs charged to additional paid in capital $ 172,750